We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPGY
3001
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
-726,232
Closed -$18.8M
CTXS
3002
DELISTED
Citrix Systems Inc
CTXS
-29,812
Closed -$3.88M
FST
3003
DELISTED
FAST Acquisition Corp.
FST
-16,637
Closed -$170K
TPTX
3004
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-13,115
Closed -$1.6M
MSP
3005
DELISTED
Datto Holding Corp.
MSP
-82,772
Closed -$2.23M
TACA.U
3006
DELISTED
Trepont Acquisition Corp I Units, each consisting of one Class A ordinary share and one-half of one
TACA.U
-500,000
Closed -$5.18M
CAS.U
3007
DELISTED
Cascade Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half o
CAS.U
-600,000
Closed -$6.27M
OCA.U
3008
DELISTED
Omnichannel Acquisition Corp. Units, each consisting of one share of Class A common stock and one-ha
OCA.U
-350,000
Closed -$3.6M
ATRS
3009
DELISTED
Antares Pharma, Inc.
ATRS
-95,522
Closed -$381K
HMHC
3010
DELISTED
Houghton Mifflin Harcourt Company
HMHC
-410,627
Closed -$1.37M
TLMD
3011
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
-43,218
Closed -$339K
RVI
3012
DELISTED
Retail Value Inc. Common Shares
RVI
-313,574
Closed -$428K
GSKY
3013
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
-169,415
Closed -$784K
MOTV.U
3014
DELISTED
Motive Capital Corp Units, each consisting of one Class A ordinary share, and one-third of one redee
MOTV.U
-500,000
Closed -$5.27M
ARNA
3015
DELISTED
Arena Pharmaceuticals Inc
ARNA
-6,102
Closed -$469K
OMP
3016
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
-13,514
Closed -$159K
ODT
3017
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
-24,243
Closed -$466K
DRNA
3018
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-31,591
Closed -$696K
ZIXI
3019
DELISTED
Zix Corporation
ZIXI
-19,123
Closed -$165K
IIAC.U
3020
DELISTED
Investindustrial Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
IIAC.U
-600,000
Closed -$6.17M
INOV
3021
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-74,446
Closed -$1.35M
XONE
3022
DELISTED
The ExOne Company
XONE
-10,983
Closed -$104K
KDMN
3023
DELISTED
Kadmon Holdings, Inc.
KDMN
-99,870
Closed -$414K
MRACU
3024
DELISTED
Marquee Raine Acquisition Corp. Unit
MRACU
-200,000
Closed -$2.17M
CTAC.U
3025
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
-1,000,000
Closed -$10.7M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.